Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies
Mateusz Kciuk, Adrianna Gielecińska, Somdutt Mujwar, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 1278-1298
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Cancer Therapeutic Targeting of Hypoxia Induced Carbonic Anhydrase IX: From Bench to Bedside
Paul C. McDonald, Shawn C. Chafe, Claudiu T. Supuran, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3297-3297
Open Access | Times Cited: 76
Carbonic anhydrase IX: An atypical target for innovative therapies in cancer
Roberto Ronca, Claudiu T. Supuran
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 4, pp. 189120-189120
Open Access | Times Cited: 25
Design of novel anti-cancer drugs targeting TRKs inhibitors based 3D QSAR, molecular docking and molecular dynamics simulation
Mohammed Er-rajy, Mohamed El fadili, Somdutt Mujwar, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 21, pp. 11657-11670
Open Access | Times Cited: 34
QSAR, molecular docking, and molecular dynamics simulation–based design of novel anti-cancer drugs targeting thioredoxin reductase enzyme
Mohammed Er-rajy, Mohamed El fadili, Somdutt Mujwar, et al.
Structural Chemistry (2023) Vol. 34, Iss. 4, pp. 1527-1543
Closed Access | Times Cited: 23
Identification of thienopyrimidine derivatives tethered with sulfonamide and other moieties as carbonic anhydrase inhibitors: Design, synthesis and anti-proliferative activity
Samah Higazy, Nermin Samir, Ahmed El‐Khouly, et al.
Bioorganic Chemistry (2024) Vol. 144, pp. 107089-107089
Closed Access | Times Cited: 12
Novel sulfonamide-tethered Schiff bases as anti-proliferative agents with VEGFR-2 inhibitory activity: Synthesis, biological assessment, and molecular dynamic simulations
Moataz A. Shaldam, Maha-Hamadien Abdulla, Andrea Angeli, et al.
Journal of Molecular Structure (2024) Vol. 1309, pp. 138148-138148
Closed Access | Times Cited: 8
Synthesis of new sulfonamide derivatives: Investigation of their interactions with carbonic anhydrase and cholinesterase enzymes by in vitro and in silico evaluations
Muhammet Gürkan Kurban, Reşit Çakmak, Eyüp Başaran, et al.
Journal of Molecular Structure (2024) Vol. 1314, pp. 138798-138798
Closed Access | Times Cited: 8
Indole Derivatives: A Versatile Scaffold in Modern Drug Discovery—An Updated Review on Their Multifaceted Therapeutic Applications (2020–2024)
Xingyou Mo, Devendra Pratap Rao, Kirandeep Kaur, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4770-4770
Open Access | Times Cited: 8
Emerging Role of Extracellular pH in Tumor Microenvironment as a Therapeutic Target for Cancer Immunotherapy
Md. Ataur Rahman, Mahesh Kumar Yadab, Meser M. Ali
Cells (2024) Vol. 13, Iss. 22, pp. 1924-1924
Open Access | Times Cited: 8
Recent advances of anti-tumor nano-strategies via overturning pH gradient: alkalization and acidification
Qiufang Gong, Xuejiao Song, Yao Tong, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Preparation of Novel Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine Sulfonamides and Their Experimental and Computational Biological Studies
Mateusz Kciuk, Somdutt Mujwar, Anna Szymanowska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 5892-5892
Open Access | Times Cited: 30
Novel Thiopyrano[2,3-d]thiazole-pyrazole Hybrids as Potential Nonsulfonamide Human Carbonic Anhydrase IX and XII Inhibitors: Design, Synthesis, and Biochemical Studies
Nadia H. Metwally, Ebrahim Adel El-Desoky
ACS Omega (2023) Vol. 8, Iss. 6, pp. 5571-5592
Open Access | Times Cited: 18
Association between pH regulation of the tumor microenvironment and immunological state
Masahiro Hosonuma, Kiyoshi Yoshimura
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 18
Targeting hypoxic and acidic tumor microenvironment by nanoparticles: A review
Mohamed J. Saadh, Mohammed Ahmed Mustafa, Laith Yassen Qassem, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 96, pp. 105660-105660
Closed Access | Times Cited: 7
Unveiling sultam in drug discovery: spotlight on the underexplored scaffold
Yie Kie Chong, Yee Swen Ong, Keng Yoon Yeong
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 6, pp. 1798-1827
Closed Access | Times Cited: 6
Computational Bioprospecting Guggulsterone against ADP Ribose Phosphatase of SARS-CoV-2
Mateusz Kciuk, Somdutt Mujwar, Isha Rani, et al.
Molecules (2022) Vol. 27, Iss. 23, pp. 8287-8287
Open Access | Times Cited: 26
Latest Advances in Specific Inhibition of Tumor-Associated Carbonic Anhydrases
Claudiu T. Supuran
Future Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 5-7
Closed Access | Times Cited: 15
PET radiotracers and fluorescent probes for imaging human carbonic anhydrase IX and XII in hypoxic tumors
Sridhar Goud Nerella, Priti Singh, Pavitra S. Thacker, et al.
Bioorganic Chemistry (2023) Vol. 133, pp. 106399-106399
Closed Access | Times Cited: 14
Selenium-analogs based on natural sources as cancer-associated carbonic anhydrase isoforms IX and XII inhibitors
Nora Astrain-Redín, Niccolò Paoletti, Daniel Plano, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 14
A comparative study of diaryl urea molecules with and without sulfonamide group on Carbonic anhydrase IX and XII inhibition and its consequence on breast cancer cells
Joy Debnath, Dhananjaya Keshamasetthy, Jacob Combs, et al.
Bioorganic Chemistry (2024) Vol. 145, pp. 107192-107192
Closed Access | Times Cited: 5
Belzutifan for patients with von Hippel-Lindau disease-associated CNS haemangioblastomas (LITESPARK-004): a multicentre, single-arm, phase 2 study
Othon Iliopoulos, Ane B. Iversen, Vivek Narayan, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 10, pp. 1325-1336
Closed Access | Times Cited: 5
Interactions of novel 1,3-diaryltriazene-sulfamethazines with carbonic anhydrases: Kinetic studies and in silico simulations
Nebih Lolak, Cüneyt Türkeş, Süleyman Akocak, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 761, pp. 110181-110181
Closed Access | Times Cited: 5
CRISPRi/a screens in human iPSC-cardiomyocytes identify glycolytic activation as a druggable target for doxorubicin-induced cardiotoxicity
Chunying Liu, Mengcheng Shen, Yanxia Liu, et al.
Cell stem cell (2024)
Closed Access | Times Cited: 5
Design, synthesis, cytotoxic evaluation and molecular docking of novel 1, 3, 4-thiadiazole sulfonamides with azene and coumarin moieties as carbonic anhydrase inhibitors
Samir Bondock, Tallah Albarqi, Tamer Nasr, et al.
Arabian Journal of Chemistry (2023) Vol. 16, Iss. 8, pp. 104956-104956
Open Access | Times Cited: 12
Discovery of Novel Hydroxyimine-Tethered Benzenesulfonamides as Potential Human Carbonic Anhydrase IX/XII Inhibitors
Mudasir Nabi Peerzada, Daniela Vullo, Niccolò Paoletti, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 6, pp. 810-819
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top